Myopia Unknown Status Phase 2 / 3 Trials for Atropine (DB00572)

Also known as: Short-sighted / Short sightedness / Nearsighted

IndicationStatusPhase
DBCOND0009460 (Myopia)Unknown Status2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00371124Safety and Efficacy Study of 0.5%, 0.1% & 0.01% Atropine Treatment to Both Eyes In Treatment of Myopia In ChildrenTreatment